SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277932
Filing Date
2023-11-15
Accepted
2023-11-15 16:41:00
Documents
12
Period of Report
2023-11-15
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d893873d8k.htm   iXBRL 8-K 28024
  Complete submission text file 0001193125-23-277932.txt   150529

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20231115.xsd EX-101.SCH 2539
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20231115_lab.xml EX-101.LAB 17957
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20231115_pre.xml EX-101.PRE 11257
6 EXTRACTED XBRL INSTANCE DOCUMENT d893873d8k_htm.xml XML 3754
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36577 | Film No.: 231411130
SIC: 2834 Pharmaceutical Preparations